Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.67 | -32.94 |
| PEG Ratio (TTM) | -34.87 | -2.90 |
| P/S Ratio (TTM) | N/A | 50.30 |
| P/B Ratio (TTM) | 1.05 | 6.94 |
| P/FCF Ratio (TTM) | -644.45 | -209.89 |
| Price to 5YR AVG Earnings Ratio | N/A | -29.45 |
| Price to 5YR AVG FCF Ratio | N/A | -26.95 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.61% | 48.68% |
| ROE (TTM) | 3.84% | -546.16% |
| Net Profit Margin (TTM) | N/A | -357.17% |
| ROIC 5YR AVG | N/A | 831.74% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 62.75% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | 3.17% | N/A | N/A |
| Cash Flow | -6.05% | N/A | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.32 | 4.84 |
| Quick Ratio (TTM) | 0.22 | 24.36 |
| D/E Ratio (TTM) | 0.00 | 0.25 |
| Interest Coverage (TTM) | 1.12 | 3.72 |
| Piotroski F-Score | 2 | 3 |
| Altman Z-Score | N/A | 21.88 |
| LTL to 5YR AVG FCF | N/A | -1.27 |
| Shares Outstanding Growth 5YR AVG | N/A | 515.59% |